A citation-based method for searching scientific literature

Lilian Wang, Roberta M Strigel. Radiol Clin North Am 2021
Times Cited: 3







List of co-cited articles
11 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force.
Joy Melnikow, Joshua J Fenton, Evelyn P Whitlock, Diana L Miglioretti, Meghan S Weyrich, Jamie H Thompson, Kunal Shah. Ann Intern Med 2016
179
66

Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications.
Jessica A Cintolo-Gonzalez, Danielle Braun, Amanda L Blackford, Emanuele Mazzola, Ahmet Acar, Jennifer K Plichta, Molly Griffin, Kevin S Hughes. Breast Cancer Res Treat 2017
80
66

Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline.
Kala Visvanathan, Patricia Hurley, Elissa Bantug, Powel Brown, Nananda F Col, Jack Cuzick, Nancy E Davidson, Andrea Decensi, Carol Fabian, Leslie Ford,[...]. J Clin Oncol 2013
207
66

Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR.
Debra L Monticciolo, Mary S Newell, Linda Moy, Bethany Niell, Barbara Monsees, Edward A Sickles. J Am Coll Radiol 2018
237
66

Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer.
Carol H Lee, D David Dershaw, Daniel Kopans, Phil Evans, Barbara Monsees, Debra Monticciolo, R James Brenner, Lawrence Bassett, Wendie Berg, Stephen Feig,[...]. J Am Coll Radiol 2010
422
66

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
66

Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level.
Tracy Onega, Elisabeth F Beaber, Brian L Sprague, William E Barlow, Jennifer S Haas, Anna N A Tosteson, Mitchell D Schnall, Katrina Armstrong, Marilyn M Schapira, Berta Geller,[...]. Cancer 2014
91
66

Contrast-Enhanced Spectral Mammography in Women With Intermediate Breast Cancer Risk and Dense Breasts.
Vera Sorin, Yael Yagil, Ady Yosepovich, Anat Shalmon, Michael Gotlieb, Osnat Halshtok Neiman, Miri Sklair-Levy. AJR Am J Roentgenol 2018
44
66

Supplemental MRI Screening for Women with Extremely Dense Breast Tissue.
Marije F Bakker, Stéphanie V de Lange, Ruud M Pijnappel, Ritse M Mann, Petra H M Peeters, Evelyn M Monninkhof, Marleen J Emaus, Claudette E Loo, Robertus H C Bisschops, Marc B I Lobbes,[...]. N Engl J Med 2019
181
66

A Case-Control Study to Add Volumetric or Clinical Mammographic Density into the Tyrer-Cuzick Breast Cancer Risk Model.
Adam R Brentnall, Wendy F Cohn, William A Knaus, Martin J Yaffe, Jack Cuzick, Jennifer A Harvey. J Breast Imaging 2019
19
66

Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.
Adam R Brentnall, Jack Cuzick, Diana S M Buist, Erin J Aiello Bowles. JAMA Oncol 2018
90
66

Validation of the breast cancer surveillance consortium model of breast cancer risk.
Jeffrey A Tice, Michael C S Bissell, Diana L Miglioretti, Charlotte C Gard, Garth H Rauscher, Firas M Dabbous, Karla Kerlikowske. Breast Cancer Res Treat 2019
26
33

Combining quantitative and qualitative breast density measures to assess breast cancer risk.
Karla Kerlikowske, Lin Ma, Christopher G Scott, Amir P Mahmoudzadeh, Matthew R Jensen, Brian L Sprague, Louise M Henderson, V Shane Pankratz, Steven R Cummings, Diana L Miglioretti,[...]. Breast Cancer Res 2017
21
33

BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.
D Shattuck-Eidens, A Oliphant, M McClure, C McBride, J Gupte, T Rubano, D Pruss, S V Tavtigian, D H Teng, N Adey,[...]. JAMA 1997
288
33

Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials.
Jack Cuzick, Adam R Brentnall, Corrinne Segal, Helen Byers, Caroline Reuter, Simone Detre, Elena Lopez-Knowles, Ivana Sestak, Anthony Howell, Trevor J Powles,[...]. J Clin Oncol 2017
41
33


Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics.
A C Antoniou, R Hardy, L Walker, D G Evans, A Shenton, R Eeles, S Shanley, G Pichert, L Izatt, S Rose,[...]. J Med Genet 2008
129
33

Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.
D A Berry, G Parmigiani, J Sanchez, J Schildkraut, E Winer. J Natl Cancer Inst 1997
259
33

One versus Two Breast Density Measures to Predict 5- and 10-Year Breast Cancer Risk.
Karla Kerlikowske, Charlotte C Gard, Brian L Sprague, Jeffrey A Tice, Diana L Miglioretti. Cancer Epidemiol Biomarkers Prev 2015
16
33

Breast cancer risk prediction: an update to the Rosner-Colditz breast cancer incidence model.
Megan S Rice, Shelley S Tworoger, Susan E Hankinson, Rulla M Tamimi, A Heather Eliassen, Walter C Willett, Graham Colditz, Bernard Rosner. Breast Cancer Res Treat 2017
10
33

Abbreviated MRI Protocols: Wave of the Future for Breast Cancer Screening.
Chloe M Chhor, Cecilia L Mercado. AJR Am J Roentgenol 2017
37
33

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
693
33

A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes.
A C Antoniou, P D P Pharoah, G McMullan, N E Day, M R Stratton, J Peto, B J Ponder, D F Easton. Br J Cancer 2002
315
33

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
Douglas K Owens, Karina W Davidson, Alex H Krist, Michael J Barry, Michael Cabana, Aaron B Caughey, Chyke A Doubeni, John W Epling, Martha Kubik, C Seth Landefeld,[...]. JAMA 2019
152
33

A Deep Learning Mammography-based Model for Improved Breast Cancer Risk Prediction.
Adam Yala, Constance Lehman, Tal Schuster, Tally Portnoi, Regina Barzilay. Radiology 2019
131
33



Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium.
Christine Fischer, Karoline Kuchenbäcker, Christoph Engel, Silke Zachariae, Kerstin Rhiem, Alfons Meindl, Nils Rahner, Nicola Dikow, Hansjörg Plendl, Irmgard Debatin,[...]. J Med Genet 2013
50
33

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.
Mary B Daly, Robert Pilarski, Matthew B Yurgelun, Michael P Berry, Saundra S Buys, Patricia Dickson, Susan M Domchek, Ahmed Elkhanany, Susan Friedman, Judy E Garber,[...]. J Natl Compr Canc Netw 2020
167
33

The protective role of pregnancy in breast cancer.
Jose Russo, Raquel Moral, Gabriela A Balogh, Daniel Mailo, Irma H Russo. Breast Cancer Res 2005
226
33

Risk-based Breast Cancer Screening: Implications of Breast Density.
Christoph I Lee, Linda E Chen, Joann G Elmore. Med Clin North Am 2017
35
33

Impact of adding breast density to breast cancer risk models: A systematic review.
Bolette Mikela Vilmun, Ilse Vejborg, Elsebeth Lynge, Martin Lillholm, Mads Nielsen, Michael Bachmann Nielsen, Jonathan Frederik Carlsen. Eur J Radiol 2020
12
33

Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study.
A C Antoniou, P D Pharoah, G McMullan, N E Day, B A Ponder, D Easton. Genet Epidemiol 2001
209
33

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.
Andrew Lee, Nasim Mavaddat, Amber N Wilcox, Alex P Cunningham, Tim Carver, Simon Hartley, Chantal Babb de Villiers, Angel Izquierdo, Jacques Simard, Marjanka K Schmidt,[...]. Genet Med 2019
177
33

'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer.
M C Pike, M D Krailo, B E Henderson, J T Casagrande, D G Hoel. Nature 1983
526
33

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.
T S Frank, S A Manley, O I Olopade, S Cummings, J E Garber, B Bernhardt, K Antman, D Russo, M E Wood, L Mullineau,[...]. J Clin Oncol 1998
332
33

Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis.
Heidi D Nelson, Bernadette Zakher, Amy Cantor, Rongwei Fu, Jessica Griffin, Ellen S O'Meara, Diana S M Buist, Karla Kerlikowske, Nicolien T van Ravesteyn, Amy Trentham-Dietz,[...]. Ann Intern Med 2012
231
33


Validity of models for predicting BRCA1 and BRCA2 mutations.
Giovanni Parmigiani, Sining Chen, Edwin S Iversen, Tara M Friebel, Dianne M Finkelstein, Hoda Anton-Culver, Argyrios Ziogas, Barbara L Weber, Andrea Eisen, Kathleen E Malone,[...]. Ann Intern Med 2007
77
33

Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model.
Andrew J Lee, Alex P Cunningham, Marc Tischkowitz, Jacques Simard, Paul D Pharoah, Douglas F Easton, Antonis C Antoniou. Genet Med 2016
53
33

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.
Thomas S Frank, Amie M Deffenbaugh, Julia E Reid, Mark Hulick, Brian E Ward, Beth Lingenfelter, Kathi L Gumpper, Thomas Scholl, Sean V Tavtigian, Dmitry R Pruss,[...]. J Clin Oncol 2002
641
33

BayesMendel: an R environment for Mendelian risk prediction.
Sining Chen, Wenyi Wang, Karl W Broman, Hormuzd A Katki, Giovanni Parmigiani. Stat Appl Genet Mol Biol 2004
53
33

Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort.
Adam R Brentnall, Elaine F Harkness, Susan M Astley, Louise S Donnelly, Paula Stavrinos, Sarah Sampson, Lynne Fox, Jamie C Sergeant, Michelle N Harvie, Mary Wilson,[...]. Breast Cancer Res 2015
111
33


Projecting individualized absolute invasive breast cancer risk in African American women.
Mitchell H Gail, Joseph P Costantino, David Pee, Melissa Bondy, Lisa Newman, Mano Selvan, Garnet L Anderson, Kathleen E Malone, Polly A Marchbanks, Worta McCaskill-Stevens,[...]. J Natl Cancer Inst 2007
196
33

Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density.
Jinbo Chen, David Pee, Rajeev Ayyagari, Barry Graubard, Catherine Schairer, Celia Byrne, Jacques Benichou, Mitchell H Gail. J Natl Cancer Inst 2006
240
33

Rating the risk factors for breast cancer.
S Eva Singletary. Ann Surg 2003
152
33

Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
Lois B Travis, Deirdre Hill, Graça M Dores, Mary Gospodarowicz, Flora E van Leeuwen, Eric Holowaty, Bengt Glimelius, Michael Andersson, Eero Pukkala, Charles F Lynch,[...]. J Natl Cancer Inst 2005
269
33

Breast Cancer Risk Assessment Models and High-Risk Screening.
Lora D Barke, Mary E Freivogel. Radiol Clin North Am 2017
12
33

A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density.
Adam R Brentnall, Elke M van Veen, Elaine F Harkness, Sajjad Rafiq, Helen Byers, Susan M Astley, Sarah Sampson, Anthony Howell, William G Newman, Jack Cuzick,[...]. Int J Cancer 2020
18
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.